METHODS FOR THE TREATMENT OF HEPATITIS B AND HEPATITIS D VIRUS INFECTIONS

It is disclosed a method for treating hepatitis b virus infection or hepatitis b virus / hepatitis delta virus co-infection, the method comprising administering to a subject in need of such treatment a first pharmaceutically acceptable agent that comprises at least one phosphorothioated nucleic acid...

Full description

Saved in:
Bibliographic Details
Main Author VAILLANT, Andrew
Format Patent
LanguageEnglish
French
Published 17.05.2017
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:It is disclosed a method for treating hepatitis b virus infection or hepatitis b virus / hepatitis delta virus co-infection, the method comprising administering to a subject in need of such treatment a first pharmaceutically acceptable agent that comprises at least one phosphorothioated nucleic acid polymer and a second pharmaceutically acceptable agent that comprises at least one nucleoside / nucleotide analog hbv polymerase inhibitor. L'invention concerne un procédé pour traiter une infection par le virus de l'hépatite b ou une co-infection par le virus de l'hépatite b et par le virus de l'hépatite d, ce procédé consistant à administrer à un sujet ayant besoin d'un tel traitement un premier agent pharmaceutiquement acceptable qui comprend au moins un polymère d'acide nucléique phosphorothioaté et un second agent pharmaceutiquement acceptable qui comprend au moins un analogue de nucléoside/nucléotide inhibiteur de la polymérase du vhb.
Bibliography:Application Number: MA20150040218